Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. SK3 Group Inc. (SKTO) Message Board

The SKTO horse is run ready. Dharmanol as a househ

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36729
Posted On: 12/29/2013 12:48:27 PM
Posted By: bellsandwhistles
Re: theFutureisBright #15522
The SKTO horse is run ready. Dharmanol as a household name is not improbable down the road. The broad spectrum of both organic cannabinoids (THCA, CBDA, CBD etc.) and terpernoids -- extracted and stabilized from whole cannabis (through a proprietary process) -- with added organic hemp oil is an arsenal of healing power against a wide range of maladies. For example, non-psychoactive Dharmanol can serve as an analgesic (pain reliever) -- as well as play its role in disease prevention and as a treatment option for various disorders and serious maladies. It's a good bet Dharmanol will one day be found in the pharmacy section of every big box retailer.

National Cancer Institute: "CBD, in particular, is thought to have significant analgesic and anti-inflammatory activity without the psychoactive effect (high) of delta-9-THC."

ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF CONSTITUENTS OF CANNABIS SATIVA L.
INFLAMMATION, Vol 12, No. 4, 1988
E.A. Formukong, A.T. Evans, and F.J. Evans
Department of Pharmacognosy, The School of Pharmacy University of London,
29-39 Brunswick Square London, WC11N 1AX, England

Scientists at Temple University in Philadelphia who are exploring the medical benefits of cannabidiol (CBD), a marijuana compound that does not produce the high associated with THC, have found that it's effective in helping prevent neuropathic pain. CBD, the second major cannabinoid in pot after THC, has anti-inflammatory and pain-relieving properties, but no psychoactive effects, according to the scientists, reports Tom Avril at Philly.com.

Temple University School of Pharmacy
Sara Ward, Temple University: "From what we've seen so far, it's almost a complete prevention of the onset of neuropathic pain"


(0)
(0)




SK3 Group Inc. (SKTO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us